hotspot -WSS

hotspot

author：hotspot 2025-09-28 01:39:43 - browse：3939

A protestor wears a transgender flag at a hearing on banning gender-affirming health care legislation in Missouri. AP Photo/Charlie Riedel

The American Academy of Pediatrics reaffirmed its support for gender-affirming medical care for transgender children on Thursday, even as the treatments face a growing push for bans and restrictions from Republican lawmakers across the U.S.

The board of directors for the group, which represents 67,000 pediatricians, unanimously voted to reaffirm its 2018 position on the treatments. The board also voted to provide additional documents to support pediatricians, including clinical and technical reports, and to conduct an external review of research regarding the care.

“The additional recommendations also reflect the fact that the board is concerned about restrictions to accessing evidence-based health care for young people who need it,” Mark Del Monte, the academy’s CEO, said in a statement released by the group, calling the restrictions enacted by states “unprecedented government intrusion.”

“We therefore need to provide the best and most transparent process possible,” he said.

At least 21 states have now enacted laws restricting or banning gender-affirming medical care for transgender minors, and most of those states face lawsuits. A federal judge struck down Arkansas’ ban as unconstitutional, and federal judges have temporarily blocked bans in Alabama and Indiana.

The judge who struck down Arkansas’ ban cited the position of the groups in his ruling against the ban. Arkansas has appealed the judge’s decision.

People opposed to such treatments for children argue they are too young to make such decisions about their futures.

Every major medical group, including the academy and the American Medical Association, has opposed the bans and has said the treatments are safe if administered properly.

The academy and the AMA support allowing children to seek the medical care, but they don’t offer age-specific guidance.

Previous article： How one medical school became remarkably diverse
Next article： Researchers CRISPR chickens in bid to protect them from bird flu

WSS

Nick Jonas talks about managing diabetes along with his career

What the Wegovy shortage looks like for doctors — and for patients

There’s no way to know how good AI health technologies are

Wellcome Trust names Røttingen as its new CEO

European regulators consider appeal over Amylyx ALS drug

Eight reasons why you should get an updated Covid vaccine

explore

hotspot

hotspot

Cancer drug shortages should be causing more outrage

STAT Readout: Today's biotech news includes Sana and Amylyx

Apple is now the first public company to be valued at $3 trillion

Akero's treatment for NASH falls short in cirrhosis study

New air purifier tech could be key to improving indoor air quality

European regulators consider appeal over Amylyx ALS drug

Walensky prepares to leave CDC — and Congress — behind

European regulators consider appeal over Amylyx ALS drug

Trump demands the U.S. pay no more for drugs than other countries … again

Bernie Sanders bashes nonprofit hospitals over their tax breaks

leisure time

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Latest bird flu infection made farmworker sicker than earlier cases

Insmed lung disease drug hits target in key Phase 3 trial

How should state employee insurance handle Wegovy?

Insmed lung disease drug hits target in key Phase 3 trial

Health insurers say they are turning to AI to cut costs, improve care

hotspot

entertainment

hotspot

focus